Dr. Joseph Ross, MD

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing A Risk Evaluation and Mitigation Program for Transmucosal Fentanyl Prescribing, 2019-03-29

• Financial Stress and Outcomes after Acute Myocardial Infarction, 2012-10-24

• Age-related Trajectories of Cardiovascular Risk and Use of Aspirin and Statin among US Adults Aged 50 or Older, 2011-2018, 2021-02-17

• Advanced access scheduling outcomes: A systematic review, 2011-04-25

• Association between payments by pharmaceutical manufacturers and prescribing behavior in Rheumatology, 2022-04-09

• National Prescribing Trends of High-risk Anticholinergic Medications in Older Adults, 2018-03-26

• Biomedical journal speed and efficiency: a cross-sectional pilot survey of author experiences, 2018-01-05

• Home Health Care after Skilled Nursing Facility Discharge Following Heart Failure Hospitalization, 2019-10-11

• Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study, 2018-10-23

• Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration, 2019-10-11

• Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use, 2021-06-05

• Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence, 2019-10-09

• Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels Generic vs Brand-Name Levothyroxine for Hypothyroidism, 2020-09-30

• Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017 Clinical Trials Supporting FDA Approval of Novel Therapeutic Agents, 1995-2017, 2020-04-21

• Association of Receipt of Paycheck Protection Program Loans With Staffing Patterns Among US Nursing Homes Receipt of Paycheck Protection Program Loans and Staffing Patterns in US Nursing Homes, 2023-07-27

• Hospital-based, acute care utilization among patients recently discharged from the hospital, 2013-01-23

• Age of Data at the Time of Publication of Contemporary Clinical Trials Age of Data at the Time of Publication of Contemporary Clinical Trials, 2018-08-10

• STEPS: A NARRATIVE ACCOUNT OF A GABAPENTIN SEEDING TRIAL, 2011-06-27

• Generic Atorvastatin and Health Care Costs, 2011-12-07

• The Cost Implications of Prostate Cancer Screening in the Medicare Population, 2013-10-04

• Patterns and predictors of off-label prescription of psychiatric drugs, 2018-07-19

• Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019 Diabetes Medications for Adults With Commercial Insurance vs Medicare Advantage, 2021-02-01

• Physician clinical management strategies and reasoning: a cross-sectional survey using clinical vignettes of eight common medical admissions, 2014-04-17

• ANTIHYPERGLYCEMIC MEDICATION PRESCRIBING AND STATE MEDICAID PROGRAM RESPONSES TO ROSIGLITAZONE SAFETY WARNINGS, 2012-03-27

• Transparency and Accountability of Medicaid Section 1115 Waiver Demonstration Programs Under the Affordable Care Act Transparency and Accountability of Medicaid Section 1115 Waiver Demonstration Programs, 2020-10-26

• Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA, 2021-11-17

• US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018, 2021-04-16

• Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA, 2020-07-23

• GENERIC DRUGS IN THE UNITED STATES: POLICIES TO ADDRESS PRICING AND COMPETITION, 2019-01-10

• Inconsistencies among European Union Pharmaceutical Regulator Safety Communications: A Cross-Country Comparison, 2014-10-21

• Quality of Care in the United States Territories, 1999-2012, 2019-04-17

• Unplanned hospital visits after ambulatory surgical care, 2021-07-20

• Hospital-based, acute care following ambulatory surgery center discharge, 2013-12-14

• Poorly Cited Articles in Peer-Reviewed Cardiovascular Journals from 1997-2007: Analysis of 5-Year Citation Rates, 2015-03-26

• Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults Postoperative Use of Gabapentinoids and Opioids Among Older Adults, 2023-06-16

• Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines and Content for Safe Prescribing, 2011-08-17

• Physician incentives to improve quality and the delivery of high quality ambulatory medical care, 2012-04-01

• The Importance of Clinical Trial Data Sharing: Toward More Open Science, 2012-03-01

• Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data, 2020-02-16

• Hospital-based, acute care use among patients within 30-days of discharge after coronary artery bypass surgery, 2013-05-21

• Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock Mechanical Circulatory Support Device Use Among Patients With AMI and Cardiogenic Shock, 2021-02-22

• Reporting of substance use treatment quality in United States adult drug courts, 2020-12-10

• Use of Fibrates in the United States and Canada, 2011-03-23

• Risk of Readmission after Discharge from Skilled Nursing Facilities Following Heart Failure Hospitalization: A Retrospective Cohort Study, 2019-01-29

• Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics, 2021-04-20

• National trends in stroke after acute myocardial infarction among Medicare patients in the United States: 1999 to 2010, 2014-06-14

• Evaluation of a Mobile Acute Care for the Elderly Service, 2013-06-10

• New and incremental FDA black box warnings from 2008 to 2015, 2017-12-17

• Development and use of an administrative claims measure for profiling hospital-wide performance on 30-day unplanned readmission, 2014-11-18

• Safety and Effectiveness of a Catheter With Contact Force and 6-Hole Irrigation for Ablation of Persistent Atrial Fibrillation in Routine Clinical Practice Comparison of Catheters for Ablation of Persistent Atrial Fibrillation, 2022-08-17

• Attitudes of Hospital Leaders TowardsPublicly Reported Measures of Health Care Quality, 2014-12-01

• The Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults, 2016-05-24

• The Cost of Breast Cancer Screening in the Medicare Population, 2013-02-11

• Impact of Drug Policy on Regional Trends in Ezetimibe Use, 2014-06-03

• Expanding the Frontier of Outcomes Measurement for Public Reporting, 2011-01-01

• Aggregating multiple real-world data sources using a patient-centered health-data-sharing platform, 2020-04-20

• Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic Project, 2017-02-15

• Accuracy of Computable Phenotyping Approaches for SARS-CoV-2 Infection and COVID-19 Hospitalizations from the Electronic Health Record, 2021-05-13

• U.S. Prescribing Trends of Fentanyl, Opioids, and Other Pain Medications in Outpatient and Emergency Department Visits from 2006-2015, 2019-03-17

• Clinical research data sharing: what an open science world means for researchers involved in evidence synthesis, 2016-09-20

• VISITS FOR PRIMARY CARE SERVICES TO PRIMARY CARE AND SPECIALTY CARE PHYSICIANS, 1999 AND 2007, 2012-10-08

• Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017, 2020-04-01

• Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey, 2014-10-02

• Impact of left ventricular assist devices and heart transplants on acute myocardial infarction and heart failure mortality and readmission measures, 2020-03-26

• The Open Translational Science in Schizophrenia (OPTICS) project: an open-science project bringing together Janssen clinical trial and NIMH data, 2018-06-27

• Rates of, and factors associated with, switching among generic levothyroxine preparations in commercially insured American adults, 2022-02-02

• Hospital characteristics associated with risk-standardized readmission rates, 2017-03-17

• CORONARY ARTERY BYPASS GRAFT: CONTEMPORARY HEART SURGERY CENTER PERFORMANCE IN CHINA, 2012-03-06

• State-Sponsored Public Reporting Programs of Hospital Quality in the United States, 2011-01-05

• Recent trends in chronic disease, impairment and disability among older adults in the United States, 2011-08-18

• Adherence to the International Committee of Medical Journal Editors' (ICMJE) prospective registration policy and implications for outcome integrity: a cross-sectional analysis of trials published in high-impact specialty society journals, 2018-08-23

• Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs Availability of Investigational Medicines Prior to FDA Approval, 2018-06-15

• Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011 Postmarket Clinical Evidence for Premarket-Approved High-Risk Medical Devices, 2020-08-28

• Impact of the ENHANCE Trial on the Use of Ezetimibe in the United States and Canada, 2014-02-26

• Association of the FDA Amendment Act with trial registration, publication, and outcome reporting, 2017-07-18

• Drug labeling changes and pediatric hematology/oncology prescribing: measuring the impact of U.S. legislation, 2021-07-16

• Prevalence of Inadequate Blood Pressure Control Among Veterans After Acute Ischemic Stroke Hospitalization: A Retrospective Cohort, 2011-06-21

• For-Profit Hospital Ownership Status and Use of Brachytherapy after Breast-Conserving Surgery, 2013-12-15

• Impact of SGLT2 inhibitors in comparison to DPP4 inhibitors on ascites and death in veterans with cirrhosis on metformin, 2021-07-28

• Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021 Approvals and Timing of New Formulations of Novel Drugs Between 1995 and 2010 and Followed Through 2021, 2022-05-20

• Physical activity, patient-reported symptoms, and clinical events: Insights into postprocedural recovery from personal digital devices, 2021-07-03

• Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval, 2018-12-01

• A multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations, 2022-03-08

• Loneliness, sadness, and feelings of social disconnection in older adults during the COVID-19 pandemic, 2021-12-10

• Non-inferiority Trials Using a Surrogate Marker as a Primary Endpoint: An Increasing Phenotype in Cardiovascular Trials, 2020-08-24

• Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries Clinician Trends in Prescribing Direct Oral Anticoagulants for Medicare Beneficiaries, 2021-12-06

• Relationship of Hospital Performance with Readmission and Mortality Rates for Patients Hospitalized with Acute Myocardial Infarction, Heart Failure, or Pneumonia, 2013-02-13

• Association of Chronic Diseases and Impairments with Disability in Older Adults: A Decade of Change?, 2012-01-19

• Development and validation of an algorithm to identify planned readmissions from claims data, 2015-07-07

• Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments Postapproval Clinical Trials of Therapeutics Approved by the FDA Without Clinical Postmarketing Requirements, 2019-05-10

• PHARMACEUTICAL-INDUSTRY SPONSORED RESEARCH: PROMOTING TRANSPARENCY, 2011-11-28

• Impact of US industry payment disclosure laws on payments to surgeons: a natural experiment, 2020-01-03

• Intensive Treatment and Severe Hypoglycemia Among Adults With Type 2 Diabetes, 2016-07-01

• CORRELATION OF INPATIENT AND OUTPATIENT MEASURES OF STROKE CARE QUALITY WITHIN VETERANS HEALTH ADMINISTRATION HOSPITALS, 2011-06-30

• Mortality and Readmission at Safety Net and Non-Safety Net Hospitals for Three Common Medical Conditions, 2012-11-16

• Moving Forward from rhBMP-2: Open Science and Data Sharing, 2014-04-01

• Overview and experience of the YODA Project with clinical trial data sharing after 5 years, 2018-11-27

• Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016 Opioid and Benzodiazepine Coprescription Rates After 2016 Release of CDC Guidelines, 2019-08-02

• Place of Residence and Outcomes of Patients with Heart Failure: An Analysis from the Tele-HF Trial, 2014-07-29

• Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals, 2016-04-14

• Assessment of Preprint Policies of Top-Ranked Clinical Journals Assessment of Preprint Policies of Top-Ranked Clinical Journals, 2020-07-22

• FDA Policy and Cardiovascular Medicine, 2015-09-22

• Association of Racial and Socioeconomic Disparities With Outcomes Among Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, and Pneumonia An Analysis of Within- and Between-Hospital Variation Association of Race and Income With Outcomes for AMI, Heart Failure, and Pneumonia, 2018-09-07

• Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017 CMS Spending Before and After Confirmed Benefit of Drugs With Accelerated Approval, 2022-05-27

• TIME TO PUBLICATION AMONG COMPLETED CLINICAL TRIALS, 2013-05-13

• Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health models, 2023-08-08

• Variation in U.S. Hospital Emergency Department Admission Rates by Clinical Condition, 2015-08-13

• Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study, 2018-03-21